Aerovate Therapeutics, Inc. (AVTE) - Quarterly Income Statement

Home
AVTE
Financials

2.68 (USD) • At close April 28, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

	2025 Q2	2025 Q1	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1
Revenue Numbers are in millions	0	0	0.112	0	0	0	0.136	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost of Revenue Numbers are in millions	0	0	0.056	0	0.028	0.028	0.028	0.025	0.022	0.021	0.02	0.02	0.017	0.011	0.008	0.003	0	0.002	0	0	0	0
Gross Profit Numbers are in millions	0	0	0.056	0	-0.028	-0.028	-0.028	-0.025	-0.022	-0.021	-0.02	-0.02	-0.017	-0.011	-0.008	-0.003	-0.002	-0.002	0	0	0	0
Gross Profit Ratio Numbers are in millions	0	0	0.5	0	0	0	-0.206	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Reseach & Development Expenses Numbers are in millions	22.547	0	1.531	10.328	21.248	20.08	17.813	16.884	16.034	13.488	12.221	10.783	8.363	7.255	5.046	3.418	4.327	2.196	3.297	1.966	1.471	1.206
General & Administrative Expenses Numbers are in millions	5.231	3.387	4.872	7.082	4.917	4.538	4.253	4.484	4.302	4.151	3.631	3.369	3.852	3.764	3.222	2.782	1.447	0.584	0.366	0.277	0.154	0.152
Selling & Marketing Expenses Numbers are in millions	0	0	0	0	0	-0.028	-0.028	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
SG&A Numbers are in millions	5.231	3.387	4.872	7.082	4.917	4.51	4.225	4.484	4.302	4.151	3.631	3.369	3.852	3.764	3.222	2.782	1.447	0.584	0.366	0.277	0.154	0.152
Other Expenses Numbers are in millions	0	0	0	0	0	-0.003	0.001	0.001	-0.001	-0.001	-0.077	0.004	-0.006	0	0.001	0	-0.003	-0.001	-0.003	0	0	0
Operating Expenses Numbers are in millions	27.778	3.387	6.403	17.41	26.165	24.59	22.038	21.368	20.336	17.639	15.852	14.152	12.215	11.019	8.268	6.2	5.774	2.78	3.663	2.243	1.625	1.358
Operating Income Numbers are in millions	-27.778	-3.387	-6.403	-17.41	-26.165	-24.618	-22.066	-21.368	-20.336	-17.639	-15.852	-14.152	-12.215	-11.019	-8.268	-6.2	-5.774	-2.78	-3.663	-2.243	-1.625	-1.358
Operating Income Ratio Numbers are in millions	0	0	-57.17	0	0	0	-162.25	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income Expenses Net Numbers are in millions	-4.356	0.869	1.028	1.173	1.39	1.432	1.709	1.805	1.311	1.119	0.855	0.564	0.224	0.109	0.048	0.016	-0.001	-0.001	-0.003	-0.064	-0.577	-0.078
Income Before Tax Numbers are in millions	-32.134	-2.518	-5.375	-16.237	-24.775	-23.186	-20.357	-19.563	-19.025	-16.52	-14.997	-13.588	-11.991	-10.91	-8.22	-6.184	-5.775	-2.781	-3.666	-2.307	-2.202	-1.436
Income Before Tax Ratio Numbers are in millions	0	0	-47.991	0	0	0	-149.684	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Income Tax Expense Numbers are in millions	0	0	0.055	0	0	-0.015	0.056	-0.025	0	-1.119	0.025	-0.564	-0.224	0	0.003	0	-0.002	-0.001	0	0	0	0
Net Income Numbers are in millions	-32.134	-2.518	-5.43	-16.237	-24.775	-23.186	-20.413	-19.563	-19.025	-15.401	-15.022	-13.024	-11.767	-10.801	-8.223	-6.184	-5.775	-2.781	-3.666	-2.307	-2.202	-1.436
Net Income Ratio Numbers are in millions	0	0	-48.482	0	0	0	-150.096	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS Numbers are in millions	-863.46	-0.09	-0.19	-0.56	-0.86	-0.83	-0.74	-0.71	-0.76	-0.62	-0.61	-0.56	-0.49	-0.45	-0.34	-0.26	-23.8	-0.13	-15.08	-10.12	-9.06	-0.32
EPS Diluted Numbers are in millions	-863.46	-0.09	-0.19	-0.56	-0.86	-0.83	-0.74	-0.71	-0.76	-0.62	-0.61	-0.56	-0.49	-0.45	-0.34	-0.26	-23.8	-0.13	-15.08	-10.12	-9.06	-0.32
EBITDA Numbers are in millions	-27.778	-3.387	-6.395	-17.192	-26.137	-24.59	-22.038	-21.343	-20.314	-17.618	-15.832	-14.132	-12.198	-11.008	-8.26	-6.197	-5.772	-2.778	-4.309	-2.243	-1.625	-1.398
EBITDA Ratio Numbers are in millions	0	0	-57.098	0	0	0	-162.044	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0

Aerovate Therapeutics, Inc.

NASDAQ:AVTE Add to watchlist

NASDAQ:AVTE